Etropal AD

Etropal AD's capital structure shows a debt-to-equity ratio of 0.8, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 1.05, suggesting it has just enough current assets to cover its current liabilities. However, the company's cash and equivalents amount to only 85,000 BGN, and its operating cash flow is negative at -145,000 BGN, raising concerns about its short-term liquidity. In terms of profitability, Etropal AD's return on equity (ROE) is 3.49%, and its return on assets (ROA) is 1.55%. These figures are below the typical thresholds for strong performance in the medical equipment industry, indicating that the company is not generating substantial returns relative to its equity and asset base. The company's revenue is concentrated in a single business segment, as it operates through one subsidiary, Etropal Trade OOD. There is no disclosed geographic diversification, and the company's operations are entirely based in Bulgaria. This concentration increases exposure to local economic and regulatory risks. Etropal AD's growth trajectory is not clearly defined in the provided data. The company's recent financial performance shows a decline in operating income and net income, with a free cash flow of 1,096,000 BGN. Without specific outlook data for the current or next fiscal year, it is difficult to assess the company's growth potential. The risk assessment for Etropal AD highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could constrain its ability to fund operations or invest in growth opportunities. No significant dilution sources are identified, and the company's capital structure does not indicate immediate pressure for equity issuance. Recent events related to Etropal AD are not detailed in the provided data. The company's major shareholder as of December 31, 2011, was Sintetika AD with a 66.53% stake. There is no information on recent filings, transcripts, or other events that could impact the company's operations or financial position.